Clara Campàs, partner and co-founder of specialized venture capital fund Asabys Partners, analyzes how the global Covid-19 crisis is affecting the sector and is optimistic about the future of investment in healthcare.
Joël Jean-Mairet, managing partner of Ysios Capital, explained how he sees this crisis from the perspective of a venture capital fund and warns that continued investment in healthcare innovation is more necessary than ever.
Dr. Marta-Gaia Zanchi, founder and managing partner of Nina Capital, explains how the Covid-19 pandemic could affect investment in digital health and medical technology.
Biocat will provide support for the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic. 5 of these projects are researching new therapies using very diverse strategies. Let’s look at what they’re working on.
Montserrat Vendrell, partner in the Alta Life Sciences investment fund, explains how investors are experiencing the Covid-19 pandemic and highlights one of the few positives that may come out of this crisis: new opportunities in the healthcare sector.
Lluís Pareras, founding partner of the new fund Invivo Ventures, is optimistic about the future of the life sciences sector and warns that companies need to keep working at a good pace these months so they don’t lose inertia.
Barcelona, 27 March 2020.- Barcelona will once again host BIO-Europe Spring (BES), the European partnering congress that specializes in biotechnology and the pharmaceutical industry, which will take place in the city from March 22 to 24, 2021.
The event is organized by EBD Group, which has chosen Barcelona again to host the fair after ...